0001415889-24-022859.txt : 20240904
0001415889-24-022859.hdr.sgml : 20240904
20240904205155
ACCESSION NUMBER: 0001415889-24-022859
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240901
FILED AS OF DATE: 20240904
DATE AS OF CHANGE: 20240904
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ragosa Mark
CENTRAL INDEX KEY: 0001835458
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38492
FILM NUMBER: 241279463
MAIL ADDRESS:
STREET 1: C/O KINIKSA PHARMACEUTICALS CORP.
STREET 2: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals International, plc
CENTRAL INDEX KEY: 0001730430
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 23 OLD BOND STREET, FLOOR 3
CITY: LONDON
STATE: X0
ZIP: WIS 4PZ
BUSINESS PHONE: 7814319100
MAIL ADDRESS:
STREET 1: 23 OLD BOND STREET, FLOOR 3
CITY: LONDON
STATE: X0
ZIP: WIS 4PZ
FORMER COMPANY:
FORMER CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd.
DATE OF NAME CHANGE: 20180205
4
1
form4-09052024_120941.xml
X0508
4
2024-09-01
0001730430
Kiniksa Pharmaceuticals International, plc
KNSA
0001835458
Ragosa Mark
23 OLD BOND STREET, THIRD FLOOR
LONDON
X0
W1S 4PZ
UNITED KINGDOM
false
true
false
false
CHIEF FINANCIAL OFFICER
0
Class A Ordinary Share
2024-09-01
4
M
0
4444
A
24313
D
Class A Ordinary Share
2024-09-01
4
F
0
2260
26.74
D
22053
D
Class A Ordinary Share
2024-09-02
4
M
0
1861
A
23914
D
Class A Ordinary Share
2024-09-02
4
F
0
956
26.74
D
22958
D
Restricted Share Unit
2024-09-01
4
A
0
6365
0
A
Class A Ordinary Share
6365
6365
D
Share Option
26.74
2024-09-01
4
A
0
33150
0
A
2034-08-31
Class A Ordinary Share
33150
33150
D
Restricted Share Unit
2024-09-01
4
M
0
2694
0
D
Class A Ordinary Share
2694
5388
D
Restricted Share Unit
2024-09-01
4
M
0
1750
0
D
Class A Ordinary Share
1750
5250
D
Restricted Share Unit
2024-09-02
4
M
0
1861
0
D
Class A Ordinary Share
1861
1861
D
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024.
The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021.
/s/ Madelyn Zeylikman, Attorney-in-Fact
2024-09-04